|
AP1S2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63613567139009E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.4432899320127E-15 |
| Normal-vs-Stage2 |
5.56099999999837E-05 |
| Normal-vs-Stage3 |
1.68240000042452E-07 |
| Normal-vs-Stage4 |
2.34229999995783E-06 |
| Stage1-vs-Stage2 |
6.503400E-01 |
| Stage1-vs-Stage3 |
1.808300E-02 |
| Stage1-vs-Stage4 |
5.109800E-02 |
| Stage2-vs-Stage3 |
1.179420E-01 |
| Stage2-vs-Stage4 |
1.427770E-01 |
| Stage3-vs-Stage4 |
9.337800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.63946634046397E-12 |
| Normal-vs-AfricanAmerican |
2.028300E-04 |
| Normal-vs-Asian |
4.768000E-02 |
| Caucasian-vs-AfricanAmerican |
7.736400E-01 |
| Caucasian-vs-Asian |
7.272600E-01 |
| AfricanAmerican-vs-Asian |
7.018400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.67554858876429E-12 |
| Normal-vs-Female |
3.68179930987367E-11 |
| Male-vs-Female |
8.270400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.662200E-03 |
| Normal-vs-Age(41-60Yrs) |
1.89104287784403E-12 |
| Normal-vs-Age(61-80Yrs) |
3.32478489184496E-12 |
| Normal-vs-Age(81-100Yrs) |
9.278800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.715800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.849600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.136350E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.956600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.444500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.356960E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.393100E-04 |
| Normal-vs-Grade 2 |
1.64857016926589E-12 |
| Normal-vs-Grade 3 |
1.18399956505755E-10 |
| Normal-vs-Grade 4 |
2.34639999999731E-05 |
| Grade 1-vs-Grade 2 |
1.764980E-01 |
| Grade 1-vs-Grade 3 |
4.823900E-03 |
| Grade 1-vs-Grade 4 |
6.984100E-03 |
| Grade 2-vs-Grade 3 |
1.961660E-02 |
| Grade 2-vs-Grade 4 |
2.065800E-02 |
| Grade 3-vs-Grade 4 |
5.024200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.77236045021345E-15 |
| Normal-vs-ccB subtype |
4.58749704890238E-11 |
| ccA subtype-vs-ccB subtype |
2.706600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.77500245005058E-12 |
| Normal-vs-N1 |
3.358500E-02 |
| N0-vs-N1 |
6.649600E-01 |
|
|
